Vimarsana
Biggest News Aggregation in the World

Page 34 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Millions earmarked for vaccine research was misappropriated, watchdog says - Vimarsana News

Millions earmarked for vaccine research was misappropriated, watchdog says

Millions earmarked for vaccine research was misappropriated, watchdog says By Audrey McNamara January 28, 2021 / 3:35 PM / CBS News Millions of dollars intended for vaccine research and public health emergencies were for years misused by the Department of Health and Human Services, according to a new report from independent watchdog group U.S. Office of Special Counsel. An anonymous whistleblower sparked an investigation into HHS' Office of the Assistant Secretary for Preparedness and Response's, (ASPR) use of funds intended for the Biomedical Advanced Research and Dev...

Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma - Vimarsana News

Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma

Share this article Share this article PRINCETON, N.J., Jan. 7, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has signed an exclusive Supply, Distribution and Services Agreement with Daavlin.  Securing long-term supply and distribution of a commercially ready light device is an integral component of the regulatory and commercial strategy for SGX301 (synthetic hypericin) for the treatme...

Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients - Vimarsana News

Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

A transcript of the presentation will be archived for 30 days following the event. About Oral Mucositis Mucositis is the clinical term for damage done to the mucosa by anticancer therapies. It can occur in any mucosal region, but is most commonly associated with the mouth, followed by the small intestine. It is estimated, based upon review of historic published studies and reports and an interpolation of data on the incidence of mucositis, that mucositis affects approximately 500,000 people in the U.S. per year and occurs in 40% of patients receiving chemotherapy. Mucositis can be severely de...

Detailed text transcripts for TV channel - MSNBC - 20111030:14:55:00 - Vimarsana News

Detailed text transcripts for TV channel - MSNBC - 20111030:14:55:00

Winter. not surprisinglsurprisingly, wew unprepared we really were back then. how much have we improved since then? >> well, so for dark winter, specifically, they were simulating the effects of a smallbox attack, and smallpox is a very interesting case, in part because the virus itself is extremely limited in its accessibility. and so the only way terrorist cells would be able to get smallpox is either by synthesizing, which is extremely difficult to do, or by getting loose smallpox in the same way they might acquire loose nukes from us, from an old soviet lab. so for smallpox itself, the thr...

Detailed text transcripts for TV channel - FOXNEWS - 20100226:09:24:00 - Vimarsana News

Detailed text transcripts for TV channel - FOXNEWS - 20100226:09:24:00

No-bid contract with firms to ties to democrat. tonight in fox include exclusive, correspondent james rosen has a similar account on what could be life and death in post-9/11 era. >> from the terror of the anthrax attacks born an initiative president bush called project bioshield. >> the budget will have $6 million to make available effective vaccine and treatment. >> since then, handful of biodefense firms using lobbyists and the competitive bidding conferentract had huge awards. the department of health and human services announced its intention to steer without competitive bidding up to $78...